BBBY Fundamental Analysis - BED BATH & BEYOND INC

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to BBBY. BBBY was compared to 123 industry peers in the Specialty Retail industry. BBBY may be in some trouble as it scores bad on both profitability and health. BBBY is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year BBBY has reported negative net income.

In the past year BBBY has reported a negative cash flow from operations.

The reported net income has been mixed in the past 5 years: BBBY reported negative net income in multiple years.

The reported operating cash flow has been mixed in the past 5 years: BBBY reported negative operating cash flow in multiple years.

1.2 Ratios

BBBY's Return On Assets of -34.99% is on the low side compared to the rest of the industry. BBBY is outperformed by 87.90% of its industry peers.

With a Return On Equity value of -71.57%, BBBY is not doing good in the industry: 72.58% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-34.99%
ROE	-71.57%
ROIC	N/A

ROA(3y)-39%

ROA(5y)-15.57%

ROE(3y)-83.49%

ROE(5y)-37.9%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 24.19%, BBBY is not doing good in the industry: 75.00% of the companies in the same industry are doing better.

BBBY's Gross Margin has been stable in the last couple of years.

The Profit Margin and Operating Margin are not available for BBBY so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	24.19%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.78%

GM growth 5Y0.73%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

BBBY does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for BBBY has been increased compared to 1 year ago.

BBBY has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, BBBY has a worse debt to assets ratio.

2.2 Solvency

BBBY has an Altman-Z score of 0.38. This is a bad value and indicates that BBBY is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 0.38, BBBY is doing worse than 76.61% of the companies in the same industry.

BBBY has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.

Looking at the Debt to Equity ratio, with a value of 0.09, BBBY is in the better half of the industry, outperforming 69.35% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.09
Debt/FCF	N/A
Altman-Z	0.38

ROIC/WACCN/A

WACC9.51%

2.3 Liquidity

BBBY has a Current Ratio of 1.17. This is a normal value and indicates that BBBY is financially healthy and should not expect problems in meeting its short term obligations.

BBBY has a worse Current ratio (1.17) than 64.52% of its industry peers.

BBBY has a Quick Ratio of 1.14. This is a normal value and indicates that BBBY is financially healthy and should not expect problems in meeting its short term obligations.

BBBY has a Quick ratio of 1.14. This is in the better half of the industry: BBBY outperforms 78.23% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.17
Quick Ratio	1.14

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 50.98% over the past year.

Looking at the last year, BBBY shows a very negative growth in Revenue. The Revenue has decreased by -27.23% in the last year.

The Revenue has been decreasing by -0.56% on average over the past years.

EPS 1Y (TTM)50.98%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%85.71%

Revenue 1Y (TTM)-27.23%

Revenue growth 3Y-20.31%

Revenue growth 5Y-0.56%

Sales Q2Q%-17.42%

3.2 Future

The Earnings Per Share is expected to grow by 16.37% on average over the next years. This is quite good.

The Revenue is expected to grow by 28.03% on average over the next years. This is a very strong growth

EPS Next Y81.73%

EPS Next 2Y37.89%

EPS Next 3Y24.7%

EPS Next 5Y16.37%

Revenue Next Year-27.11%

Revenue Next 2Y-12.5%

Revenue Next 3Y-6.21%

Revenue Next 5Y28.03%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

BBBY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BBBY. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

BBBY's earnings are expected to grow with 24.70% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y37.89%

EPS Next 3Y24.7%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for BBBY!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

BED BATH & BEYOND INC

NYSE:BBBY (12/19/2025, 8:04:00 PM)

After market: 6.04 +0.02 (+0.33%)

6.02

-0.15 (-2.43%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Discretionary Distribution & Retail

GICS IndustrySpecialty Retail

Earnings (Last)10-27 2025-10-27/amc

Earnings (Next)02-23 2026-02-23/amc

Inst Owners64.09%

Inst Owner Change0%

Ins Owners1.57%

Ins Owner Change0.02%

Market Cap414.48M

Revenue(TTM)1.07B

Net Income(TTM)-145.00M

Analysts75.38

Price Target11.63 (93.19%)

Short Float %9.14%

Short Ratio3.02

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)44.49%

Min EPS beat(2)42.46%

Max EPS beat(2)46.52%

EPS beat(4)3

Avg EPS beat(4)-2.72%

Min EPS beat(4)-121.07%

Max EPS beat(4)46.52%

EPS beat(8)3

Avg EPS beat(8)-31.6%

EPS beat(12)6

Avg EPS beat(12)-34.79%

EPS beat(16)9

Avg EPS beat(16)-26.03%

Revenue beat(2)1

Avg Revenue beat(2)3.76%

Min Revenue beat(2)-3.07%

Max Revenue beat(2)10.58%

Revenue beat(4)1

Avg Revenue beat(4)-5.56%

Min Revenue beat(4)-21.15%

Max Revenue beat(4)10.58%

Revenue beat(8)3

Avg Revenue beat(8)-3.55%

Revenue beat(12)5

Avg Revenue beat(12)-3.5%

Revenue beat(16)6

Avg Revenue beat(16)0.74%

PT rev (1m)5.56%

PT rev (3m)4.59%

EPS NQ rev (1m)0%

EPS NQ rev (3m)25.96%

EPS NY rev (1m)0%

EPS NY rev (3m)17.52%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-1.85%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-0.85%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.39
P/FCF	N/A
P/OCF	N/A
P/B	2.05
P/tB	2.74
EV/EBITDA	N/A

EPS(TTM)-2.5

EYN/A

EPS(NY)-0.55

Fwd EYN/A

FCF(TTM)-1.38

FCFYN/A

OCF(TTM)-1.04

OCFYN/A

SpS15.6

BVpS2.94

TBVpS2.19

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-34.99%
ROE	-71.57%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	24.19%
FCFM	N/A

ROA(3y)-39%

ROA(5y)-15.57%

ROE(3y)-83.49%

ROE(5y)-37.9%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.78%

GM growth 5Y0.73%

F-Score5

Asset Turnover2.59

Health

		Industry Rank	Sector Rank
Debt/Equity	0.09
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	122.66%
Cap/Sales	2.18%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.17
Quick Ratio	1.14
Altman-Z	0.38

F-Score5

WACC9.51%

ROIC/WACCN/A

Cap/Depr(3y)142.46%

Cap/Depr(5y)112.5%

Cap/Sales(3y)1.7%

Cap/Sales(5y)1.27%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)50.98%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%85.71%

EPS Next Y81.73%

EPS Next 2Y37.89%

EPS Next 3Y24.7%

EPS Next 5Y16.37%

Revenue 1Y (TTM)-27.23%

Revenue growth 3Y-20.31%

Revenue growth 5Y-0.56%

Sales Q2Q%-17.42%

Revenue Next Year-27.11%

Revenue Next 2Y-12.5%

Revenue Next 3Y-6.21%

Revenue Next 5Y28.03%

EBIT growth 1Y54.49%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year83.93%

EBIT Next 3Y28.34%

EBIT Next 5Y28.87%

FCF growth 1Y-39.2%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-242.34%

OCF growth 3YN/A

OCF growth 5YN/A

BED BATH & BEYOND INC / BBBY FAQ

What is the ChartMill fundamental rating of BED BATH & BEYOND INC (BBBY) stock?

ChartMill assigns a fundamental rating of 2 / 10 to BBBY.

What is the valuation status for BBBY stock?

ChartMill assigns a valuation rating of 1 / 10 to BED BATH & BEYOND INC (BBBY). This can be considered as Overvalued.

What is the profitability of BBBY stock?

BED BATH & BEYOND INC (BBBY) has a profitability rating of 1 / 10.

Can you provide the expected EPS growth for BBBY stock?

The Earnings per Share (EPS) of BED BATH & BEYOND INC (BBBY) is expected to grow by 81.73% in the next year.

BED BATH & BEYOND INC (BBBY) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

BED BATH & BEYOND INC / BBBY FAQ

What is the ChartMill fundamental rating of BED BATH & BEYOND INC (BBBY) stock?

What is the valuation status for BBBY stock?

What is the profitability of BBBY stock?

Can you provide the expected EPS growth for BBBY stock?